Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha (Q43600832)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha |
scientific article |
Statements
1 reference
Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha (English)
1 reference
M Gianni'
1 reference
Y Kalaç
1 reference
I Ponzanelli
1 reference
A Rambaldi
1 reference
M Terao
1 reference
E Garattini
1 reference
1 May 2001
1 reference
1 reference
97
1 reference
10
1 reference
3234-3243
1 reference
Identifiers
1 reference
1 reference